Colchicine derivatives

Details Colchicine derivatives Colchicine derivatives

2003-04-14

2004-11-30

Wilson, James O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S618000, C514S619000, C564S182000, C564S162000, C564S163000, C536S001110, C536S004100

Reexamination Certificate

active

06825236

ABSTRACT:

INTRODUCTION
1. Field of the Invention
This invention relates to novel colchicine derivatives that are useful for treating various types of cancer.
2. Background of the Invention
Colchicine is a known compound having the following formula
The rings are referred to as A (the phenyl ring showing methoxygroups at 1, 2, and 3), B (7-membered ring with the amide group at 7), and C (the third ring). The compound has been used to treat gout and also exhibits antitumor activity.
The antitumor activity of colchicine, which is the major alkaloid of the autumn crocus,
Colchicum autumnale,
and the African climbing lily,
Gloriosa superba,
was first reported at the beginning of the 20
th
century. The elucidation of its structure was finally completed from X-ray studies and a number of total syntheses (see Shiau et al. J. Pharm. Sci. 1978, 67(3) 394-397). Colchicine is thought to be a mitotic poison, particularly in tyhmic, intestinal, and hermatopoietic cells, which acts as a spindle poison and blocks the kinesis. Its effect on the mitotic spindle is thought to represent a special case of its effects on various organized, labile, fibrillar systems concerned with structure and movement.
Thiocolchicine is a compound of the above formula, wherein the 10-methoxy group is replaced by a 10-methylthio group. The removal of the acetyl group from the 7-position results in N-deacetylcolchicine or N-deactylthiocolchicine. We have now discovered new derivatives of colchicine and thiocolchicine that exhibit useful anticancer activity.
SUMMARY OF THE INVENTION
One aspect of this invention is a compound represented by the formula
wherein
R is C(O)—(CHR
4
)
m
—A—R
1
where
m is 1-10,
A is S, O, N or a covalent bond,
R
1
is substituted phenyl or substituted benzoyl;
B is methoxy or methylthio;
R
2
is methoxy, hydroxy, or methylenedioxy when taken together with R
3
;
R
3
is methoxy, hydroxy, a monosaccharide radical, or is methylenedioxy when taken together with R
2
; and
R
4
is H or is H or methyl when m is 1.
Another aspect of this invention is a compound represented by the formula
wherein
R is C(O)—(CHR
4
)
m
—A—R
1
where
m is 0-10;
A is oxygen, sulfur, nitrogen, or a covalent bond;
R
1
is phenyl substituted with one to five substituents (the substituents being selected from halo, lower alkyl, cyano, nitro, amino, halogenated lower alkyl, carbonyl, hydroxycarbonyl, lower alkylcarbonyloxy, benzyloxy, optionally substituted 5 or 6 membered heterocyclic ring, an imide ring, lower alkoxycarbonyl, and lower alkylcarbonylamino, optionally substituted cycloalkyl of 3-7 carbons, optionally substituted naphtyl, an optionally substituted imide ring, an optionally substituted 5 or 6 member heterocycle (with at least one N, S, or O in the ring), or an optionally substituted fused heterocyclic or fused carboxyclic ring system;
B is methoxy or methylthio;
R
2
is methoxy, hydroxy, or methylenedioxy when taken together with R
3
;
R
3
is methoxy, hydroxy, a monosaccharide radical, or is methylenedioxy when taken together with R
2
; and
R
4
is H or H or methyl when m is 1.
Another aspect of this invention is a compound represented by the formula
wherein
B is methoxy or methylthio;
R
2
is methoxy, hydroxy, or methylenedioxy when taken together with R
3
;
R
3
is methoxy, hydroxy, a monosaccharide radical, or is methylenedioxy when taken together with R
2
; and
X is a linking group.
Another aspect of the invention is a pharmaceutical composition useful for treating cancer in a warm-blooded animal, which composition comprises compound of the invention as defined herein in combination with a pharmaceutically acceptable excipient.
Another aspect of this invention is a method for treating cancer in a warm-blooded animal, which method comprises administering a therapeutically effective amount of a compound of the invention as defined herein. The compound is administered in a therapeutically effective dose by appropriate administration, e.g. orally, topically, or parenterally.
Other aspects of this invention will be apparent to one of skill in the art by reviewing the ensuing specification.


REFERENCES:
patent: 5220002 (1993-06-01), Akiyama
patent: 5777136 (1998-07-01), Bombardelli
patent: 5973204 (1999-10-01), Bombardelli
patent: 6080739 (2000-06-01), Bombardelli
patent: WO 91/02084 (1991-02-01), None
patent: WO 01/68597 (2001-09-01), None
The American Heritage Dictionary of the English Language, Third Edition, 1992.*
Sharma et al “Synthesis and Binding to Tubulin of Colchicine Spin Probes”, J. Med. Chem. 1984, 27, 1729-1733.*
Guan et al “Antitumor Agents. Synthesis and Biological Evaluation of Tridemethylthiocolchicine Analogues as Novel Topoisomerase II Inhibitors”, J. Med. Chem. 1998, 41, 1956-1961.*
Floyd et al “Photoafinity Labeling of Tubulin with (2-nitro-4-azidopheynyl)deacetylcolchicime: Direct evidence for two colchicine binding sites”, Biochemistry, 1989, 28(21) 8515-8525.*
Sun, L., et al., 1993, “Antitumor Agents. 141. Synthesis and Biological Evaluation of Novel Thiocolchicine Analogs: N-Acyl-, N-Aroyl-, and N-(Substituted benzyl)deacetylthiocolchicimes as Potent Cytotoxic and Antimitotic Compounds”,J. Med. Chem.,36:1474-1479.
Zang, S., et al., “Antitumor Agents. 196. Substituted 2-Thienyl-1,8-naphthyridin-4ones: their Synthesis, Cytotoxicity, and Inhibition of Tubulin Polymerization”,J. Med. Chem., 42:4081-4087.
Brossi, A., et al., 1983, Biological Effects of Modified Colchicines. 2. Evalution of Catecholic Colchicines, Colchifolines, Colchicide, and Novel N—Acyl—and N—Aroyldeacetylcolchicines,J. Med. Chem., 26, 1365-1369.
De Vincenzo, R., et al., 1998, “Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell lines”Anti-Cancer Drug Design, 13:19-33.
Dumont, R., et al, 1987, “A Novel Synthesis of Colchicide and Analogues from Thiocolchicine and Congeners: Reevalution of Colchicide as a Potenial Antitumor Agent”,J. Med Chem., 30:732-735.
Gelmi, M.L., et al., 1999, “N-Deacetyl-N-aminoacylthicolchicine Derivatives: Synthesis and Biological Evaluation on MDR-Positive and MDR-Negative Human Cancer Cell Lines”,J. Med. Chem., 42:5272-5276.
Kerekes, P. et al. 1985, “Synthesis and Biological Effects of Novel Thiocolchicines. 3. Evaluation of N-Acyldeacetylthiocolchicines, N-(Alkoxycarbonyl)deacetylthiocolchicines, and O-Ethyldemethylthiocolchicines. New Synthesis of Thiodemecolcine and Antileukemic Effects of Demethyl-and 3-Demethylthiocolchicine”,J. Med. Chem., 28:1204-1208.
Lin, T., et al., 1980, “Synthesis and Biological Activities of Chloroethylurea, Methylurea, and Nitrosourea Analogues of N-Deacetylmethylthiocolchicine”,J. Med., Chem., 23:1440-1442.
Muzaffar, A., et al., 1990, “Antiubulin Effects of Derivatives of 3-Demethylthiocolchine, Methylthio Ethers of Natural Colchicinoids, and Thioketones Derived from Thiocolchicine. Comparison with Colchicinoids”, 33:567-571.
Rösner, M., 1981, “Biological Effects of Modified Colchicines. Improved Preparation of 2-Demethylcolchicine, 3-Demethylcochicine, and (+)-Colchicine and Reassignment of the Position of the Double Bond in Dehydro-7 deacetamidocolchicines”,J. Med. Chem., 24:257-261.
Shi, Q., et al., 1997, “Antituor Agents. 172, Synthesis and Biological Evaluation of Novel Deacetamidothicolchicin-7 ols and Ester Analogs as Antitubulin Agents”,J. Med. Chem., 40:961-966.
Shiau, G.T., et al., 1975, “Alkylthiocolchicines and N-Deacetyl-alkylthiocolchicines and Their Antileukemic Activity”,J. Pharm. Sci., 4:646-648.
Shiau, G.T., et al., 1978, “Synthesis and Evaluation of N-Deacetyl-N-glycosylalklthiocolchicines as Antileukemic Agents”,J. Pharm. Sci., 67:394-397.
Sun, L., et al., 1993, “Antitumor Agents. 139. Synthesis and Biological Evaluation of Thiocochicine Analogs 5,6-Dihydro-6(S)-(acyloxy)-and 5,6-Dihydro-6(S)-[aroyloxy)methyl]-1,2,3, -trimethoxy-9-(methylthio)-8H-cyclophepta[a]naphthalene-8-ones as Novel Cytotoxic and Antimitioic Agents”,J. Med. Chem., 36:544-551.

Affiliated with

Also associated with

Rating

Colchicine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Colchicine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Colchicine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3321660